Nonfatal and fatal cardiovascular disease events in CPAP compliant obstructive sleep apnea patients

[1]  E. Kaluski,et al.  A meta-analysis of continuous positive airway pressure therapy in prevention of cardiovascular events in patients with obstructive sleep apnoea , 2018, European heart journal.

[2]  J. Concato,et al.  Polysomnographic phenotypes and their cardiovascular implications in obstructive sleep apnoea , 2017, Thorax.

[3]  I. Elgendy,et al.  Meta-Analysis of Cardiovascular Outcomes With Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea. , 2017, The American journal of cardiology.

[4]  S. Yin,et al.  Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment , 2017, Sleep and Breathing.

[5]  A. Pack,et al.  Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences. , 2017, Journal of the American College of Cardiology.

[6]  J. Herlitz,et al.  Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial. , 2016, American journal of respiratory and critical care medicine.

[7]  Rui Chen,et al.  CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. , 2016, The New England journal of medicine.

[8]  M. Martínez-García,et al.  Role of sleep apnea and continuous positive airway pressure therapy in the incidence of stroke or coronary heart disease in women. , 2014, American journal of respiratory and critical care medicine.

[9]  M. Mosteiro,et al.  Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. , 2013, JAMA.

[10]  J. Montserrat,et al.  Effect of Continuous Positive Airway Pressure on the Incidence of Hypertension and Cardiovascular Events in Nonsleepy Patients With Obstructive Sleep Apnea: A Randomized Controlled Trial , 2013 .

[11]  T. Young,et al.  Increased prevalence of sleep-disordered breathing in adults. , 2013, American journal of epidemiology.

[12]  J. Montserrat,et al.  Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study. , 2012, American journal of respiratory and critical care medicine.

[13]  Gilles Barone-Rochette,et al.  Mechanisms of cardiac dysfunction in obstructive sleep apnea , 2012, Nature Reviews Cardiology.

[14]  J. Montserrat,et al.  Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. , 2012, JAMA.

[15]  A. Lurie Cardiovascular disorders associated with obstructive sleep apnea. , 2011, Advances in cardiology.

[16]  T. Young,et al.  Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun , 2008, Journal of the American College of Cardiology.

[17]  L. Bortolotto,et al.  Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. , 2007, American journal of respiratory and critical care medicine.

[18]  K. Reynolds,et al.  Effect of Nocturnal Nasal Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea , 2007, Hypertension.

[19]  W. McNicholas,et al.  Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. , 2005, Chest.

[20]  Jose M Marin,et al.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study , 2005, The Lancet.

[21]  G. Jondeau,et al.  Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. , 2004, European heart journal.

[22]  Adelaide M. Arruda-Olson,et al.  Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun , 2008, Journal of the American College of Cardiology.

[23]  Daniel J Buysse,et al.  Sleep–Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical Research , 2000 .

[24]  Daniel J Buysse,et al.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. , 1999, Sleep.

[25]  O. Gureje,et al.  The validity of two versions of the GHQ in the WHO study of mental illness in general health care , 1997, Psychological Medicine.

[26]  J. Leech,et al.  Nasal CPAP continues to improve sleep-disordered breathing and daytime oxygenation over long-term follow-up of occlusive sleep apnea syndrome. , 1992, Chest.

[27]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[28]  L. Findley,et al.  Apnea duration and hypoxemia during REM sleep in patients with obstructive sleep apnea. , 1985, Chest.

[29]  B. Phillips Long-term Cardiovascular Outcomes in Men With Obstructive Sleep Apnoea-Hypopnoea With or Without Treatment With Continuous Positive Airway Pressure: An Observational Study , 2007 .